WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026794) A NOVEL POLYPEPTIDE, A HUMAN RIBOSOMAL PROTEIN L7A20.57 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026794    International Application No.:    PCT/CN2001/001137
Publication Date: 04.04.2002 International Filing Date: 02.07.2001
IPC:
A61K 38/00 (2006.01), A61K 48/00 (2006.01), C07K 14/47 (2006.01)
Applicants: BIOWINDOW GENE DEVELOPMENT INC. SHANGHAI [CN/CN]; 12Floor 3rd Building 1111 Zhongshan Bei Er Road Shanghai 200092 (CN).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: WATSON & BAND LOW OFFICES; 61 Nanjing Road (E) 11th Floor Shanghai 200002 (CN)
Priority Data:
00 1 17098.8 07.07.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, A HUMAN RIBOSOMAL PROTEIN L7A20.57 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE RIBOSOMALE HUMAINE L7A20.57, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide, a human ribosomal protein L7a20.57, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as development disturbance disease of relative tissue, protein metabolism disturbance disease, research and diagnosis and treatment of various tumour etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel human ribosomal protein L7a20.57.
(FR)L'invention concerne un nouveau polypeptide, une protéine ribosomale humaine L7a20.57, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de maladies liées aux troubles du métabolisme des protéines et aux troubles du développement et d'études menées en vue du traitement de diverses tumeurs de même que les méthodes thérapeutiques apparentées. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la protéine ribosomale humaine L7a20.57.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)